Feinstein Institutes Get $3M From Lupus Research Alliance To Study Remission And Future Therapies
08/24/22, 2:04 PM
Money raised
$3 million
Industry
science and engineering
health care
biotechnology
Round Type
seed
Millions worldwide and an estimated 200,000 people in the United States have lupus, of whom 90 percent are women. In an effort to translate basic molecular research into better therapy for patients seeking care, The Feinstein Institutes for Medical Research has been awarded a $3 million Global Team Science Award from the Lupus Research Alliance. Betty Diamond, MD, director of the Institute of Molecular Medicine at the Feinstein Institutes and the Maureen and Ralph Nappi Professor of Autoimmune Diseases, will lead the research efforts as the corresponding investigator with a multi-disciplinary global team.
Company Info
Additional Info
The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn